Actively Recruiting
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
Led by Glaukos Corporation · Updated on 2026-01-21
230
Participants Needed
1
Research Sites
228 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Adult subjects with elevated intraocular pressure who have successfully undergone placement of iStent infinite trabecular bypass system will be randomized to receive a travoprost intraocular implant or receive a sham procedure and be followed for 12 months.
CONDITIONS
Official Title
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of open-angle glaucoma or ocular hypertension
- Qualifying intraocular pressure in the study eye
- Successful placement of the iStent infinite trabecular bypass system
- Adults aged 18 years or older
You will not qualify if you...
- Unmedicated intraocular pressure greater than 36 mmHg in the study eye
- Allergy or hypersensitivity to travoprost or components of the travoprost intraocular implant
- Vertical cup/disc ratio greater than 0.8 in the study eye
- Best corrected visual acuity worse than 20/80 in either eye
- Any ocular disease or condition that may significantly increase risk, affect study results, or interfere with participation according to investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Glaukos Clinical Study Site
Colorado Springs, Colorado, United States, 80907
Actively Recruiting
Research Team
S
Study Director
CONTACT
S
Study Manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here